radiation recall refers inflammatory reactions triggered chemotherapeutic agents develops cutaneously previously irradiated areas agents include anthracyclines taxanes capecitabine radiation recall related gemcitabine reported lung breast cancer similar phenomenon associated gemcitabine drug pancreatic cancer rarely reported report patient inoperable pancreatic cancer developed gastrointestinal bleeding secondary related gemcitabine review literature white male unresectable pancreatic cancer received capecitabine combination radiation therapy followed capecitabine given approximately time period computed tomography demonstrated new liver lesion patient treated gemcitabine irinotecan day NUMBER cycle NUMBER reported progressive worsening weakness fatigue melena physical examination revealed hypotension mmhg stool rectal examination denied aspirin antiinflammatory drug use chemotherapy held hematocrit NUMBER previously NUMBER transfused NUMBER units packed red blood cells examination performed showed antritis duodenitis consistent radiation therapy single site oozing injected epinephrine diffuse gastritis aggressively treated proton pump inhibitors patients hematocrit eventually stabilized NUMBER discharge gemcitabine resumed radiation recall gemcitabine rare potentially arise site previously irradiated gemcitabine added list drugs known cause radiation recall treating physicians aware potential toxicity gemcitabine given concomitantly followed radiation suggest discontinuing gemcitabine radiation recall observed studies warranted pathogenesis unique phenomenon fda approved radiation recall NUMBER year old NUMBER month evaluation heme positive non steroidal esophago gastro duodenal NUMBER NUMBER